CLARA: A PHASE 1/2 MULTI-CENTER, RANDOMIZED, DOUBLE MARKED, PROSPECTIVE, PARALLEL-ARM STUDY OF AURN001 IN SUBJECTS WITH CORNEAL EDEMA SECONDARY TO CORNEAL ENDOTHELIAL DYSFONCTION (ABA-1)

Registry ID

ABA-1

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

AURION BIOTECH INC.

Start date

2024-02-09

Last update

2023-12-15

Conditions

• CORNEAL ENDOTHELIAL DYSTROPHY

Related clinical trials

• A PHASE 2 CLINICAL TRIAL TO ASSESS THE SAFETY AND OBSERVE THE POTENTIAL BENEFIT OF TTHX1114 DELIVERED VIA INTRA-CAMERAL (IC) INJECTION (TTHX-901)

View on source registry